What is the Best Frontline Therapy for Patients with CLL and 17p Deletion?
- Published in:
- Current Hematologic Malignancy Reports, 2011, v. 6, n. 1, p. 36, doi. 10.1007/s11899-010-0069-3
- By:
- Publication type:
- Article
Works matching IS 15588211 AND DT 2011 AND VI 6 AND IP 1
Results: 10
1
2
The Emerging Role of Histone Deacetylase Inhibitors in Treating T-cell Lymphomas.
- Published in:
- Current Hematologic Malignancy Reports, 2011, v. 6, n. 1, p. 67, doi. 10.1007/s11899-010-0067-5
- By:
- Publication type:
- Article
3
The Search for Better Prognostic Models in Myelodysplastic Syndromes.
- Published in:
- Current Hematologic Malignancy Reports, 2011, v. 6, n. 1, p. 13, doi. 10.1007/s11899-010-0070-x
- By:
- Publication type:
- Article
4
Future Therapies for the Myeloproliferative Neoplasms.
- Published in:
- Current Hematologic Malignancy Reports, 2011, v. 6, n. 1, p. 22, doi. 10.1007/s11899-010-0068-4
- By:
- Publication type:
- Article
5
Therapeutic Modalities for Patients with Lower-Risk Myelodysplastic Syndromes: Current Options and Future Directions.
- Published in:
- Current Hematologic Malignancy Reports, 2011, v. 6, n. 1, p. 5, doi. 10.1007/s11899-010-0071-9
- By:
- Publication type:
- Article
6
Should Patients with Low-Risk Myelodysplastic Syndrome be Treated Earlier in the Course of Their Disease?
- Published in:
- Current Hematologic Malignancy Reports, 2011, v. 6, n. 1, p. 1, doi. 10.1007/s11899-010-0072-8
- By:
- Publication type:
- Article
7
Special Issues in Myeloproliferative Neoplasms.
- Published in:
- Current Hematologic Malignancy Reports, 2011, v. 6, n. 1, p. 28, doi. 10.1007/s11899-010-0073-7
- By:
- Publication type:
- Article
8
The Role of Transplantation in Diffuse Large B-Cell Lymphoma: The Impact of Rituximab Plus Chemotherapy in First-line and Relapsed Settings.
- Published in:
- Current Hematologic Malignancy Reports, 2011, v. 6, n. 1, p. 47, doi. 10.1007/s11899-010-0075-5
- By:
- Publication type:
- Article
9
Survival Advantage in CLL with Frontline FCR Therapy.
- Published in:
- Current Hematologic Malignancy Reports, 2011, v. 6, n. 1, p. 3, doi. 10.1007/s11899-010-0074-6
- By:
- Publication type:
- Article
10
Burkitt Lymphoma and Atypical Burkitt or Burkitt-like Lymphoma: Should These be Treated as Different Diseases?
- Published in:
- Current Hematologic Malignancy Reports, 2011, v. 6, n. 1, p. 58, doi. 10.1007/s11899-010-0076-4
- By:
- Publication type:
- Article